eXoZymes Ownership | Who Owns eXoZymes?
eXoZymes Ownership Summary
eXoZymes is owned by 0.74% institutional investors, 71.12% insiders, and 28.14% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.26% of its assets in eXoZymes shares.
EXOZ Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | eXoZymes | 0.74% | 71.12% | 28.14% |
| Sector | Healthcare Stocks | 35.80% | 11.87% | 52.33% |
| Industry | Biotech Stocks | 36.05% | 11.82% | 52.13% |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 7 | - | 62,895 | 0.47% | - | 133.28% | 5 | 25.00% | 1 | -50.00% |
| Dec 31, 2025 | 7 | 16.67% | 62,601 | 4.47% | - | 146.31% | 4 | 33.33% | 2 | - |
| Sep 30, 2025 | 6 | -33.33% | 59,923 | -20.51% | - | 88.24% | 3 | -57.14% | 2 | - |
| Jun 30, 2025 | 9 | 50.00% | 75,382 | -1.80% | - | 106.92% | 7 | 75.00% | 2 | - |
| Mar 31, 2025 | 6 | -14.29% | 76,767 | -21.75% | - | 62.97% | 4 | -42.86% | 2 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Institutional Extnd Mkt Idx Tr | 21.80K | 0.26% | - |
| Fidelity Extended Market Index | 10.31K | 0.12% | -38.00 |
| iShares Micro-Cap ETF | 6.35K | 0.08% | - |
| Fidelity Series Total Market Index | 2.94K | 0.04% | - |
| Spartan Extended Market Index Pool F | 2.87K | 0.03% | 38.00 |
| NT Ext Equity Mkt Index Fund - NL | 2.31K | 0.03% | - |
| NT Ext Equity Mkt Index Fund - Lending | 2.13K | 0.03% | - |
| Northern Trust Extended Eq Market Idx | 2.13K | 0.03% | - |
| Fidelity Total Market Index | 2.02K | 0.02% | - |
| Fidelity Nasdaq Composite Index | 2.00K | 0.02% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 08, 2026 | Korman Tyler Paz | Chief Scientific Officer | Sell | $7.53K |
| Apr 09, 2026 | Korman Tyler Paz | Chief Scientific Officer | Sell | $7.89K |
| Jul 02, 2025 | Heltzen Michael | Chief Executive Officer | Buy | $10.63K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 2 |
| 2025 Q3 | 1 | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
EXOZ Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools